Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Silence buys fellow RNAi firm Intradigm

Executive Summary

Bringing together their capabilities in RNA interference, Silence Therapeutics PLC has acquired privately held Intradigm for £18.3mm ($29.5mm) in stock.
Deal Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock
    • Acquisition of Private Biotech
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register